These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31738274)

  • 1. Enhancing migraine self-efficacy and reducing disability through a self-management program.
    Short AL
    J Am Assoc Nurse Pract; 2019 Nov; 33(1):20-28. PubMed ID: 31738274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Headache Education Active-Waiting Directive: A Program to Enhance Well-Being During Long Referral Wait Times.
    Lagman-Bartolome AM; Lawler V; Lay C
    Headache; 2018 Jan; 58(1):109-117. PubMed ID: 29131328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine education improves quality of life in a primary care setting.
    Smith TR; Nicholson RA; Banks JW
    Headache; 2010 Apr; 50(4):600-12. PubMed ID: 20148982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis.
    Schaetz L; Rimner T; Pathak P; Fang J; Chandrasekhar D; Mueller J; Sandor PS; Gantenbein AR
    Headache; 2020 Oct; 60(9):1947-1960. PubMed ID: 32799346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial.
    Wells RE; O'Connell N; Pierce CR; Estave P; Penzien DB; Loder E; Zeidan F; Houle TT
    JAMA Intern Med; 2021 Mar; 181(3):317-328. PubMed ID: 33315046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nursing Intervention Increases Quality of Life and Self-Efficacy in Migraine: A 1-Year Prospective Controlled Trial.
    Leroux E; Beaudet L; Boudreau G; Eghtesadi M; Marchand L; Pim H; Chagnon M
    Headache; 2018 Feb; 58(2):260-274. PubMed ID: 28913825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. German Language Adaptation of the Headache Management Self-Efficacy Scale (HMSE-G) and Development of a New Short Form (HMSE-G-SF).
    Graef JE; Rief W; French DJ; Nilges P; Nestoriuc Y
    Headache; 2015; 55(7):958-72. PubMed ID: 25904007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Soft Tissue Techniques on Headache Impact, Disability, and Quality of Life in Migraine Sufferers: A Pilot Study.
    Espí-López GV; Ruescas-Nicolau MA; Nova-Redondo C; Benítez-Martínez JC; Dugailly PM; Falla D
    J Altern Complement Med; 2018 Nov; 24(11):1099-1107. PubMed ID: 29708766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache management program improves outcome for chronic headache.
    Harpole LH; Samsa GP; Jurgelski AE; Shipley JL; Bernstein A; Matchar DB
    Headache; 2003; 43(7):715-24. PubMed ID: 12890125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program.
    Wallasch TM; Angeli A; Kropp P
    Headache; 2012; 52(7):1094-105. PubMed ID: 22703374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for care and perceptions of MIDAS among headache sufferers study.
    Stewart W; Lipton R
    CNS Drugs; 2002; 16 Suppl 1():5-11. PubMed ID: 12196034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
    Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC
    Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study.
    D'Amico D; Grazzi L; Bussone G; Curone M; Di Fiore P; Usai S; Leonardi M; Giovannetti AM; Schiavolin S; Raggi A
    Headache; 2015 May; 55(5):636-45. PubMed ID: 25913219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Therapeutic Self-Management Intervention in Adolescents With Migraine: Feasibility and Preliminary Efficacy of "Migraine Manager".
    Hommel KA; Carmody J; Hershey AD; Holbein C; Kabbouche-Samaha M; Peugh J; Powers S
    Headache; 2020 Jun; 60(6):1103-1110. PubMed ID: 32320052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms and insecure attachment as predictors of disability in a clinical population of patients with episodic and chronic migraine.
    Rossi P; Di Lorenzo G; Malpezzi MG; Di Lorenzo C; Cesarino F; Faroni J; Siracusano A; Troisi A
    Headache; 2005 May; 45(5):561-70. PubMed ID: 15953275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center.
    Seng EK; Buse DC; Klepper JE; J Mayson S; Grinberg AS; Grosberg BM; Pavlovic JM; Robbins MS; Vollbracht SE; Lipton RB
    Headache; 2017 Apr; 57(4):593-604. PubMed ID: 28139000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supportive Self-Management Program for People With Chronic Headaches and Migraine: A Randomized Controlled Trial and Economic Evaluation.
    Underwood M; Achana F; Carnes D; Eldridge S; Ellard DR; Griffiths F; Haywood K; Hee SW; Higgins H; Mistry D; Mistry H; Newton S; Nichols V; Norman C; Padfield E; Patel S; Petrou S; Pincus T; Potter R; Sandhu H; Stewart K; Taylor SJC; Matharu MS
    Neurology; 2023 Mar; 100(13):e1339-e1352. PubMed ID: 36526428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
    Ford JH; Kurth T; Starling AJ; Ayer DW; Wietecha LA; Port MD; Rettiganti M; Ruff DD
    Headache; 2020 Nov; 60(10):2304-2319. PubMed ID: 33249580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.